Parkinson’s Disease Investigational Drug Study

Now Enrolling

Parkinson’s Disease (PD) is the most common neurodegenerative disorder, affecting an estimated 10 million people worldwide. While some medications can lessen the symptoms of PD, no medication currently can address the root causes of PD and slow the progression of the disease.

Meridian is enrolling adults with PD for a clinical trial of an investigational drug.

Eligible participants…

  • Must be age 50-85
  • Must have been diagnosed with Parkinson’s disease between 6 months and 3 years ago
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

Expect Excellence icon - supporting research since 1999

Submit your information

Study Location

Meridian Clinical Research
1520 Sunday Drive, Suite 301
Raleigh, NC 27607

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.